Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | {{CMG}} | ||
{{Hyperlipidemia}} | |||
{{ | |||
==Overview== | ==Overview== | ||
Children and adolescents with high-risk [[hyperlipidemia]] require lipid-lowering drug therapy, particularly those with familial [[hypercholesterolemia]], despite compliance with lifestyle recommendations. | Children and adolescents with high-risk [[hyperlipidemia]] require lipid-lowering drug therapy, particularly those with familial [[hypercholesterolemia]], despite compliance with lifestyle recommendations. | ||
==Adjuvant | ==Adjuvant Therapies in Children and Adolescents== | ||
=== Hyperlipidemia NCEP | ===Hyperlipidemia NCEP Recommendations for Adjuvant Therapies in Children and Adolescents<ref name="pmid17377073">{{cite journal| author=McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP et al.| title=Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. | journal=Circulation | year= 2007 | volume= 115 | issue= 14 | pages= 1948-67 | pmid=17377073 | doi=10.1161/CIRCULATIONAHA.107.181946 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17377073 }} </ref> (DO NOT EDIT)=== | ||
{{cquote| | {{cquote| | ||
====The Role of Physical Activity in Management==== | |||
'''1)''' From current pediatric data, it would appear that an exercise program should be included as part of a comprehensive risk factor modification program for the prevention of cardiovascular disease in children and adolescents. | '''1)''' From current pediatric data, it would appear that an exercise program should be included as part of a comprehensive risk factor modification program for the prevention of cardiovascular disease in children and adolescents. | ||
| Line 30: | Line 19: | ||
'''3)''' More long-term data are needed to completely assess the role of physical activity in risk factor modification for the pediatric population. | '''3)''' More long-term data are needed to completely assess the role of physical activity in risk factor modification for the pediatric population. | ||
====Nonpharmacological Therapies==== | |||
'''1)''' In general, dietary recommendations should be consistent with good nutrition, aimed at a proper caloric balance to ensure optimal growth and development while preventing obesity. | '''1)''' In general, dietary recommendations should be consistent with good nutrition, aimed at a proper caloric balance to ensure optimal growth and development while preventing obesity. | ||
}} | }} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Latest revision as of 19:15, 19 February 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Lipoprotein Disorders Microchapters |
Overview
Children and adolescents with high-risk hyperlipidemia require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia, despite compliance with lifestyle recommendations.
Adjuvant Therapies in Children and Adolescents
Hyperlipidemia NCEP Recommendations for Adjuvant Therapies in Children and Adolescents[1] (DO NOT EDIT)
| “ |
The Role of Physical Activity in Management1) From current pediatric data, it would appear that an exercise program should be included as part of a comprehensive risk factor modification program for the prevention of cardiovascular disease in children and adolescents. 2) Emphasis on regular physical activity rather than improvement in aerobic capacity appears to be the best approach for structuring such a program. 3) More long-term data are needed to completely assess the role of physical activity in risk factor modification for the pediatric population. Nonpharmacological Therapies1) In general, dietary recommendations should be consistent with good nutrition, aimed at a proper caloric balance to ensure optimal growth and development while preventing obesity. |
” |
References
- ↑ McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP; et al. (2007). "Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing". Circulation. 115 (14): 1948–67. doi:10.1161/CIRCULATIONAHA.107.181946. PMID 17377073.